Results filed 3 November 2026 · Market cap ₹2,302 crore · PE 26.3
GrowthGuidance maintainedTranscript read
Revenue
+63.9%
on a year ago
EBITDA
+111.9%
on a year ago
Profit to shareholders
+85.5%
on a year ago
EBITDA margin
10.5%
−0.1 pts on last quarter
JG Chemicals reported Q2 FY27 consolidated revenue of ₹361.01 crore, up 63.9% YoY, driven by mid-teens volume growth and higher LME-linked selling prices. EBITDA rose 76.8% YoY to ₹38.65 crore with an EBITDA margin of 10.71%, although margins declined slightly sequentially due to raw material timing lags. Commissioning of the 15,000 MTPA Dahej Phase 1 facility is scheduled for trial runs in December 2026, alongside the 5,000 MTPA Naidupeta expansion slated for January 2027.
Source: J.G.Chemicals Limited’s filing to NSE, 3 November 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.
What stood out
Revenue grew 63.9% YoY to ₹361.01 crore while volume growth was in the mid-teens, driven by higher LME-linked pricing pass-through and capacity utilization above 80%SourceTranscript page 7 & 8 (Anuj Jhunjhunwala); Presentation page 23
Operating cash flow turned negative in H1 FY27 due to sharp working capital expansion, with inventories rising from ₹92 crore to ₹154 crore and trade receivables rising from ₹177 crore to ₹207 crore between March and September 2026SourceTranscript page 9 & 11 (Akshit Shetty and Anuj Jhunjhunwala); Presentation page 26
Capacity expansions at Dahej (15,000 MTPA Phase 1) and Naidupeta (5,000 MTPA brownfield) are scheduled for commissioning in Q3/Q4 FY27, expanding total capacity to 79,904 MTPASourceTranscript page 4 & 9 (Anirudh Jhunjhunwala, Anuj Jhunjhunwala); Presentation page 22
Expected to operate at 60% to 65% capacity utilization in FY28
FY28
Tailwinds
Strong demand from the automotive and tyre sectors, supported by a ~₹25,000 crore capex cycle announced by Indian tyre manufacturersSourceTranscript page 5 (Anirudh Jhunjhunwala); Presentation page 21
Operating leverage expansion, with employee and other expenses growing slower than revenue, sustaining healthy profitabilitySourceTranscript page 9 (Anirudh Jhunjhunwala); Presentation page 23
Growing contribution from non-rubber applications, exceeding 18% of sales in H1 FY27 compared to ~10% in FY24SourceTranscript page 7 & 19 (Anuj Jhunjhunwala); Presentation page 22
Headwinds
Sequential gross margin compression (~130 bps) and EBITDA margin compression (78 bps from 11.50% in Q1 to 10.72% in Q2) due to pricing lags and higher domestic procurement costs amidst shipping disruptionsSourceTranscript page 8 & 11 (Anuj Jhunjhunwala, Anirudh Jhunjhunwala); Presentation page 23
Global supply chain disruptions linked to the West Asia conflict and Ukraine war extending procurement lead times and vessel arrivalsSourceTranscript page 6 & 11 (Anirudh Jhunjhunwala, Anuj Jhunjhunwala)
New businesses and products
capacity expansion · Equipment installation underway; trial runs scheduled for next month (December 2026)
Dahej Greenfield Facility (Phase 1)
Expected benefit
Adds 15,000 MTPA zinc oxide capacity initially within a planned 40,000+ MTPA site, improving reach into Western India's ceramic, pharma, and chemicals sectors; full project revenue potential of ₹900+ crore
Risks
Lead times for customer qualifications and ramp-up execution
Timeline
Trial runs in December 2026; commercial ramp-up in Q4 FY27/FY28
Investment
₹100 crore (fully funded through internal accruals)
SourceTranscript page 4 & 9; Presentation page 8
capacity expansion · Under installation; target commissioning spilled from Q3 into mid-to-end January 2027 (Q4 FY27)
Naidupeta Brownfield Zinc Oxide Expansion
Expected benefit
Adds approximately 5,000 MTPA to zinc oxide capacity
Risks
Slight project timeline slippage
Timeline
Mid-to-end January 2027 (Q4 FY27)
Investment
Not specified
SourceTranscript page 4 & 9 (Anuj Jhunjhunwala)
new business · Pilot trials completed successfully with key tyre customers; planning full-scale industrial venture with land in place
JG TUR (Tire Upscaled Rubber)
Expected benefit
Entry into the recycled rubber segment to convert end-of-life tires into raw materials for tire makers, expanding product verticals
Risks
Commercialization risks, customer acceptance at scale
Timeline
Commercial implementation timeline to be shared at an appropriate time
new product · Launched in H1 FY27; patent pending for rubber curing activator jointly developed with IIT Kharagpur
New Product Commercialization: LabPure and JDZRA
Expected benefit
Supplies analytical grade zinc oxide via e-commerce and specialized curing activators for non-tyre rubber
Risks
Scale and customer adoption
Timeline
Commercialized in H1 FY27
Investment
Supported by the newly inaugurated R&D center at Naidupeta
SourceTranscript page 4-5; Presentation page 12
Things to check
Revenue up over 60%: check for an acquisition or a weak year-ago quarter
Operating cash flow turned negative in H1 FY27 despite reported PAT of ₹54.07 crore, as working capital absorbed significant cash with inventory jumping 68% (from ₹91.8 crore to ₹154.2 crore) and trade receivables increasing 21% (from ₹171.0 crore to ₹207.3 crore)SourceTranscript page 9 & 11; Presentation page 26
How the call went
The call was informative, with management providing clear project commissioning updates, operational data, and frank explanations regarding inventory dynamics and pricing mechanisms.
Specific or vague
Management provided detailed metrics for volume growth (mid-teens), capacity utilization (>80%), working capital cycle (90-100 days), and cash balance targets (>₹100 crore)
Candour
Management directly explained margin pressures stemming from pricing lags/lead-time discrepancies and acknowledged negative operating cash flows due to working capital expansion
The hard questions
Analysts probed working capital stress, cash burn, sequential gross margin contraction, and Naidupeta capex delay, which were answered transparently
What analysts pressed on
Negative operating cash flows in H1 FY27 and sharp expansion in inventory and receivables
Sequential gross margin reduction of ~130 bps and EBITDA margin contraction
Capex delay for Naidupeta brownfield unit moving from Q3 to Q4/mid-to-end January 2027
Sustainability of revenue growth if global zinc prices decline
Numbers against the story
Management celebrated record quarterly revenue growth of 63.9% YoY; however, underlying volume growth was in the mid-teens (~14-16%), showing that the majority of revenue growth was driven by higher pass-through zinc commodity prices rather than volume alone. Additionally, while management highlighted strong profitability, EBITDA margin dipped 78 bps QoQ, and cash flows from operations turned negative due to inventory build-up.
Figures: the company’s results filing with NSE, linked under the table.
Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.